Skip to main content
. 2022 Feb 22;57(5):742–752. doi: 10.1038/s41409-022-01604-x

Table 1.

Numbers of HCT in Europe 2020 by indication, donor type and stem cell source.

Transplant activity 2020
No. of patients
Allogeneic Autologous Total
Family Unrelated Allo Auto Total
HLA-id Twin Haplo ≥ 2MM Other family BM BM+
BM PBPC Cord all BM PBPC BM PBPC Cord BM PBPC cord only PBPC cord
Myeloid malignancies 245 2413 9 8 291 1569 12 84 5 253 5209 119 0 224 0 10,217 224 10,441
 Acute myeloid leukemia 167 1697 0 6 229 1117 9 67 4 143 3324 94 0 222 0 6857 222 7079
  1st complete remission 118 1124 0 3 131 583 6 36 3 94 1862 53 0 186 0 4013 186 4199
  Not 1st complete remission 38 393 0 3 65 374 3 24 1 36 861 30 0 31 0 1828 31 1859
 AML therapy-related or myelodysplasia-related changes 11 180 0 0 33 160 0 7 0 13 601 11 0 5 0 1016 5 1021
 Chronic myeloid leukemia 9 106 1 0 7 40 0 4 0 15 171 1 0 0 0 354 0 354
  Chronic phase 4 56 1 0 5 17 0 3 0 9 67 1 0 0 0 163 0 163
  Not chronic phase 5 50 0 0 2 23 0 1 0 6 104 0 0 0 0 191 0 191
 MDS or MD/MPN overlap 62 432 7 1 46 308 3 9 1 87 1231 23 0 0 0 2210 0 2210
 MPN 7 178 1 1 9 104 0 4 0 8 483 1 0 2 0 796 2 798
Lymphoid malignancies 280 1252 4 11 199 924 9 48 3 200 2038 78 32 21,042 0 5046 21,074 26,120
 Acute lymphatic leukemia 237 720 4 4 139 537 7 31 3 173 1106 63 0 54 0 3024 54 3078
  1st complete remission 132 498 3 1 68 274 3 16 3 81 739 31 0 51 0 1849 51 1900
  Not 1st complete remission 105 222 1 3 71 263 4 15 0 92 367 32 0 3 0 1175 3 1178
 Chronic lymphocytic leukemia 2 42 0 0 2 17 0 2 0 2 98 4 0 33 0 169 33 202
 Plasma cell disorders—MM 1 88 0 5 8 21 0 1 0 1 134 0 11 12,354 0 259 12,365 12,624
 Plasma cell disorders—other 0 7 0 0 1 4 0 0 0 1 17 0 0 401 0 30 401 431
 Hodgkin lymphoma 12 100 0 0 17 129 1 3 0 2 108 3 9 2125 0 375 2134 2509
 Non-Hodgkin lymphoma 28 295 0 2 32 216 1 11 0 21 575 8 12 6075 0 1189 6087 7276
Solid tumors 1 0 0 0 7 24 2 0 0 0 2 0 18 1667 1 36 1686 1722
 Neuroblastoma 0 0 0 0 7 20 1 0 0 0 0 0 12 492 1 28 505 533
 Soft tissue sarcoma/Ewing 1 0 0 0 0 3 0 0 0 0 0 0 3 278 0 4 281 285
 Germinal tumors 0 0 0 0 0 0 0 0 0 0 0 0 1 455 0 0 456 456
 Other solid tumors 0 0 0 0 0 1 1 0 0 0 2 0 2 442 0 4 444 448
Non-malignant disorders 586 267 21 4 119 207 58 47 2 370 469 63 4 315 0 2213 319 2532
 Bone marrow failure—SAA 168 122 0 4 35 55 8 6 0 118 151 9 0 1 0 676 1 677
 Bone marrow failure—other 43 21 1 0 14 22 10 6 0 51 53 5 0 0 0 226 0 226
 Thalassemia 120 27 12 0 3 9 12 6 0 33 53 0 0 6 0 275 6 281
 Sickle cell disease 107 56 5 0 18 11 5 1 0 15 6 0 0 1 0 224 1 225
 Primary immune deficiencies 124 27 3 0 43 92 18 25 0 107 160 22 4 1 0 621 5 626
 Inh. disorders of Metabolism 23 10 0 0 6 18 5 2 2 42 38 27 0 8 0 173 8 181
 Autoimmune disease—MS 1 0 0 0 0 0 0 0 0 0 0 0 0 226 0 1 226 227
 Autoimmune disease—SSC 0 1 0 0 0 0 0 0 0 0 0 0 0 49 0 1 49 50
 Autoimmune disease—other 0 3 0 0 0 0 0 1 0 4 8 0 0 23 0 16 23 39
 Others 28 15 0 0 5 17 2 5 0 19 37 7 0 66 0 135 66 201
Total patients 1140 3947 34 23 621 2741 83 184 10 842 7755 267 54 23,314 1 17,647 23,369 41,016
Re/additional transplants 29 123 2 1 46 382 4 11 1 46 473 31 3 3196 0 1149 3199 4348
Total transplants 1169 4070 36 24 667 3123 87 195 11 888 8228 298 57 26,510 1 18,796 26,568 45,364